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to suppress the host immune response
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Background: The pathogenic Yersinia species exhibit a primarily extracellular lifestyle through manipulation of host
signaling pathways that regulate pro-inflammatory gene expression and cytokine release. To identify host genes
that are targeted by Yersinia during the infection process, we performed an RNA interference (RNAi) screen based on
recovery of host NF-κB-mediated gene activation in response to TNF-α stimulation upon Y. enterocolitica infection.
Results: We screened shRNAs against 782 genes in the human kinome and 26 heat shock genes, and identified
19 genes that exhibited ≥40% relative increase in NF-κB reporter gene activity. The identified genes function in
multiple cellular processes including MAP and ERK signaling pathways, ion channel activity, and regulation of cell
growth. Pre-treatment with small molecule inhibitors specific for the screen hits c-KIT and CKII recovered NF-κB
gene activation and/or pro-inflammatory TNF-α cytokine release in multiple cell types, in response to either
Y. enterocolitica or Y. pestis infection.
Conclusions: We demonstrate that pathogenic Yersinia exploits c-KIT signaling in a T3SS-dependent manner to
downregulate expression of transcription factors EGR1 and RelA/p65, and pro-inflammatory cytokines. This study is
the first major functional genomics RNAi screen to elucidate virulence mechanisms of a pathogen that is primarily
dependent on extracellular-directed immunomodulation of host signaling pathways for suppression of host immunity.
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Host-pathogen interactionsBackground
The genus Yersinia includes three human pathogens,
Y. pestis, the etiological agent of plague via intradermal
fleabites or inhalation, and Y. pseudotuberculosis and Y.
enterocolitica, which cause self-limiting enteric disease
by the oral route. In spite of the differences in route of
infection and severity of disease, the three species share
similar pathogenic mechanisms, primarily the ~70 kb
virulence plasmid (pCD1 in Y. pestis and pYV in
Y. pseudotuberculosis and Y. enterocolitica) that encodes
for the Type III secretion system (T3SS) [1]. Upon con-
tact with host cells and a shift to host temperature of
37°C, Yersinia induces T3SS expression to translocate
Yersinia outer proteins (Yops) into the host cytosol to
modulate the host immune response and promote patho-
gen survival [2].* Correspondence: ehong@lanl.gov
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distribution, and reproduction in any mediumAll three Yersinia species target the lymphoid system
during infection and replicate in lymphatic tissue as ag-
gregates of extracellular bacteria [3,4]. Yersinia strains
that lack pCD1/pYV do not replicate extracellularly and
have been shown to be contained within granulomas
that are eventually eliminated [4]. Yersinia are unusual
amongst other Gram-negative bacteria that express the
T3SS, in that they do not actively induce phagocytosis
for entry and intracellular growth in the host [5]. In-
stead, Yersinia inject several Yops, including YopH, E,
and T, to disrupt the host actin cytoskeleton and resist
uptake via phagocytosis by neutrophils. Although patho-
genic Yersinia have been reported to multiply within
macrophages early in the infection process [6,7], Y. pestis
exponential growth occurs primarily in the extracellular
phase, causing acute septicemia with blood counts as
high as 108 CFU/ml [8]. Thus, in order to establish suc-
cessful infection, Yersinia is dependent on targeting mul-
tiple host signaling pathways to evade host immune
defense and induce host cell death. For example, YopP/JCentral Ltd. This is an open access article distributed under the terms of the
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ferase to inhibit both the host NF-κB and mitogen-
activated protein kinase (MAPK) signaling pathways,
leading to a block in cytokine secretion and apoptosis of
host macrophages [9-11]. Although discovery of Yop ef-
fector targets have begun to clarify mechanisms of
Yersinia virulence, it is likely the case that additional
host targets remain to be defined. Identification of host
cell factors that are targeted by Yersinia during infection
would provide valuable molecular insights in understan-
ding Yersinia pathogenesis, and ultimately, in design-
ing effective host-targeted therapies and antimicrobial
agents.
In order to systematically identify novel host targets
required for Yersinia infection, we performed an RNAi
screen using a short hairpin RNA (shRNA) kinome li-
brary. The development of RNAi approaches has greatly
enabled the examination of the roles of individual hu-
man genes by specific gene silencing [12]. Both small
and large-scale RNAi screens have been applied to the
discovery of host targets in response to infection by
intracellular pathogens, including S. typhimurium [13],
M. tuberculosis [14], and L. monocytogenes [15], and the
HIV [16-18], HCV [19,20], and influenza [21,22] viruses.
Our shRNA screen is based on the recovery of NF-κB
activation following Y. enterocolitica infection of HEK-
293 cells. NF-κB controls expression of genes involved
in the inflammatory response, including TNF-α, IL-1,
IL-6, IL-12, and MIP1β, and thus plays a critical role in
the clearance of the bacteria by the immune response.
We identified 19 host genes that are targeted by Y. entero-
colitica to inhibit NF-κB-regulated gene expression and
validated their role in host cells infected with Y. pestis,
in addition to Y. enterocolitica. We also describe a novel
c-KIT-EGR1 host signaling pathway that is targeted by
Yersinia during the infection process. To the best of our
knowledge, this is the first major RNAi effort to screen
for host targets in response to a predominantly extracel-
lular pathogen.
Results
RNAi screen to identify host cell factors that are required
for Yersinia-mediated inhibition of NF-κB-driven gene
expression
We conducted a functional genomic screen using 2503
shRNA hairpins targeting 782 human kinase and kinase-
related genes to identify host factors that inhibit NF-κB-
mediated gene expression by pathogenic Yersinia. The
screen was performed using the highly-virulent Y. en-
terocolitica WA strain, which has been shown to impair
NF-κB activation and pro-inflammatory cytokine pro-
duction more efficiently than virulent Y. pestis strains
and induces a strong apoptotic effect on host cells [23].
To maximize assay sensitivity and noise reduction forthe screen, we stimulated the HEK293 cell line with the
inflammatory mediator TNF-α, resulting in ~70-fold in-
duction of NF-κB reporter gene activity, an excellent
signal-to-noise ratio for a high throughput screen (HTS)
(Figure 1A). We calculated the Z-factor (Z’) to be ~0.65
upon infection of HEK293 at MOI 5 for 5 hrs, followed
by 18 h of TNF-α stimulation. Z’ is a statistical evalu-
ation of HTS performance and reflects the robustness
and reliability of the assay. Z’ ≥ 0.5 is equivalent to ≥ 12
standard deviations between the positive and negative
controls and represents excellent assay parameters (see
Methods for a more detailed description of Z’) [24].
We designed our screen (Figure 1B) to select for
shRNAs that increased NF-κB-driven luciferase activity
≥40% compared to the mean of all assay reads in
Y. enterocolitica-infected, TNF-α stimulated cells for
each plate. (Figure 1C, black squares compared to grey
squares) Additionally, we applied a standard z-score
method to identify shRNAs that produced a statistically-
significant recovery (z score ≥3) of luciferase activity
(Figure 1D, black diamonds).
We identified 18 kinase genes, that when silenced, led
to recovery of NF-κB-mediated luciferase activity in
response to Y. enterocolitica infection (Table 1). The
screen identified genes that function in different cellular
processes, including signal transduction (e.g., MAP ki-
nases, CKII), cytoskeleton dynamics (e.g. c-KIT, ABL,
PAK4), and regulation of ion channel activity (e.g. SGK,
WNK). In addition to the kinase shRNA library, we
screened a collection of 62 shRNA constructs that tar-
geted 26 genes annotated for chaperone activity to deter-
mine whether the heat shock, protein folding, and stress
response machinery is required for successful Yersinia
infection. We found that silencing of HSPH1, caused re-
covery of NF-κB regulated gene expression in response
to Y. enterocolitica infection (Table 1).
Validation of candidate ‘hits’ from RNAi screen
We selected 9 genes, SGK1, WNK1, c-KIT, GNE1, HSPH1,
PAK4, MAP3K3, NIK/MAP3K14, and ABL, representative
of different cellular pathways, for further validation studies.
We performed a secondary RNAi screen using a pool of
siRNA duplexes that targeted four different sequences per
gene. Introduction of the siRNA duplexes into RE-luc2P-
HEK293 cells resulted in ≥ 70% reduction in cognate gene
mRNA levels (data not shown) and reiterated the ≥40% re-
covery of TNF-α-induced NF-κB gene expression in re-
sponse to Y. enterocolitica, as previously seen in the
original shRNA screen (Figure 2A). Silencing of all nine
genes increased the ratio of NF-κB-driven luciferase acti-
vity between infected and uninfected cells (0.81 to 0.94),
when compared to HEK293 cells expressing a control
(CTL) siRNA (0.52). Similarly, siRNA silencing increased
the ratio (0.68 to 1.02) of NF-κB expression between
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Figure 1 Assay optimization and shRNA screen design. (A) Y. enterocolitica WA inhibits NF-κB signaling through TNF-R. RE-luc2P-HEK293 cells
were infected with Y. enterocolitica WA, at either MOI 0 (circles), 1 (square), or 5 (diamonds), in a 96-well plate. Cells were stimulated either 5 h
post infection with 10 ng/ml TNF-α and incubated for an additional 18 h (closed symbols) or 2 h post-infection with 10 ng/ml TNF-α and
incubated for another 5 hrs (open symbols). The arbitrary luciferase activity per well from a representative of two experiments (n=10/expt) is
presented. Z’ was calculated using the SD and mean of luciferase activity from cells infected with Y. enterocolitica WA at MOI 5 versus cells not
treated with bacteria (MOI 0) at each time point [24]. The best Z’ value 0.65 was obtained for the 18 h time point at MOI 5. (B) For the shRNA
screen, the kinome plasmid library was transfected in 96 well format, and cells were subjected to puromycin selection to enrich for populations
expressing the inhibitory sequences. Chloramphenicol (170 μg/ml) was added 1 h post-infection to control extracellular bacteria counts. At 5 h
post-infection, 10 ng/ml TNF-α was added to the cells and NF-κB-driven luciferase activity was determined 18 h later. (C) The hit selection cut-off
was determined as ≥40% direct recovery in luciferase signal of Yersinia-infected cells (black squares) relative to non-hits (gray squares) and
bacteria free samples (light gray diamonds). (D) The statistical significance of assay hit selection was evaluated using a standard z-score. Genes in
which silencing resulted in assay reads with a score ≥3 standard deviations above the assay mean score were considered to be true hits with a
strong effect on Yersinia-driven inhibition of NF-κB signaling (shown in black diamonds), compared to non-hits (gray diamonds).
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the control sample (0.49), suggesting that many of the host
genes identified from the screen are also targeted by
Y. pestis during onset of plague (Figure 2B).
To determine whether siRNA treatment itself signifi-
cantly dampened NF-κB-regulated gene expression, we
examined luciferase activity in cells treated with siRNAs
against RelB, a member of the NF-κB family. In the ab-
sence of infection, luciferase activity was decreased ~2-fold in cells treated with siRNAs against RelB, compared
to the other siRNA-treated cells. (Figure 2B, dark grey
bars, RelB in bold) Infection with the virulent Y. pestis
Ind195 strain produced no further change in luciferase
expression (Figure 2B, light grey bars, RelB), indicating
that a basal level of luciferase activity had been reached
in cells depleted of RelB. Our data suggest that siRNA
treatment alone did not significantly manipulate NF-κB
activity.
Table 1 Host genes identified from shRNAmir kinome screen required for Y. enterocolitica mediated knock-down of
NF-κB activation
Gene name Accession # Function
ABL NM_005157 Regulation of cell differentiation and adhesion
ACTR-IIB NM_001106 Activin and myostatin signaling involved in apoptosis, inflammation
CKII NM_177560 Regulation of metabolic pathways, signal transduction, transcription
ERK4/MAPK7 NM_139033 Signaling of receptor kinases and G protein-coupled receptors
GNE/DMRV NM_005476 Rate-limiting enzyme in sialic acid biosynthesis
HSPH1 NM_006644 Reduces protein aggregation and cytotoxicity through induction of HSP70
c-KIT NM_000222 Differentiation of hematopoietic progenitor cells and mast stem cells
MAP3K3 NM_002401 Regulation of NF-κB gene expression
MEK1 NM_002755 MAPK signal transduction pathways involved in transcription regulation
MONaKA/PXK NM_017771 Binds to and modulates Na,K-ATPase enzymatic and ion pump activities
NIK/MAP3K14 NM_003954 Activates NF-κB in response to TNFR and IL-1R signaling
PAK4 NM_005884 Inactivates actin binding/depolymerizing factor cofilin
PIK3R2 NM_005027 PI3K/Akt signaling associated with cell survival, proliferation
PI3-K-C2A NM_002645 Member of the PI3K family, potential role in integrin-dependent signaling
SGK1 NM_005627 Regulation of cell stress response through activation of ion channels
SGK2 NM_170693 Regulates ion channels in response to signals that activate PI3K
ULK2 NM_014683 Stress response, mediates mTOR signaling in autophagy
WNK1 NM_018979 Regulator of blood pressure by activating ion channel transporters
WNK3 NM_020922 Positive regulator of the transcellular Ca2+ transport pathway
Genes in bold were selected for further validation.
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function in Yersinia-mediated inhibition of NF-κB
activation and cytokine production
We selected three kinases, c-KIT, CKII, and SGK1, to
further validate their functions in Yersinia-mediated
NF-κB inhibition using small molecule inhibitors
(Figure 3). None of the tested kinase inhibitors in-
duced activation of NF-κB-regulated gene expression in
uninfected controls or affected Yersinia growth in host
media (data not shown). The cell surface receptor tyrosine
kinase c-KIT, also known as stem cell growth factor recep-
tor CD117, is expressed predominantly in progenitor
hematopoietic cells and mast cells. Upon stem cell factor
(SCF) ligand binding, c-KIT triggers multiple signaling
cascades, including PI3K/AKT, Ras/ERK, and JNK, which
are essential for regulating proliferation, survival and cell
differentiation [25]. Incubation of Y. enterocolitica- or
Y. pestis-infected RE-luc2P-HEK293 cells with OSI-930, a
highly-specific c-KIT inhibitor, led to rescue of TNF-α-
induced NF-κB activation, compared to no drug controls.
(Figure 3A, green vs black bars) Treatment of the mono-
cytic cell line THP-1 or primary normal human dendritic
cells (NHDC) with OSI-930 induced a similar protective
effect against Yersinia-mediated suppression of TNF-α
secretion, as measured by ELISA, indicating that
c-KIT is required for Yersinia-induced repression ofpro-inflammatory cytokine release (Figure 3B and C,
green vs black bars).
We also tested the effect of the small molecule TBB,
an inhibitor of the CKII serine kinase, which functions
in cell stress response, cell cycle and cell growth regula-
tion by activation of IKK. CKII also regulates expression
of HSPH1, another stress response gene identified in our
shRNA screen [26]. Similar to OSI930, pretreatment of
RE-luc2P-HEK293, THP-1, and NHDC cells with TBB
resulted in higher levels of NF-κB-regulated gene expres-
sion and TNF-α release compared to a no drug control,
in response to both Y. enterocolitica and Y. pestis infec-
tion (Figure 3A-C, blue vs black bars).
The small molecule CKI-7 was used to validate the role
of SGK1 (serum and glucocorticoid-inducible kinase 1) on
NF-κB-regulated gene expression in response to Yersinia
infection. SGK1 is a serine/threonine kinase that func-
tions in cellular stress response and regulates activity of
the epithelial sodium channel ENaC [27,28], a function
shared with WNK1, another kinase identified from the
shRNA screen. Incubation of RE-luc2P-HEK293 cells
with CKI-7 resulted in increased NF-κB-mediated
luciferase activity upon exposure of Y. enterocolitica
and Y. pestis-infected cells to TNF-α (Figure 3A,
purple vs black bars). However, CKI-7 did not lead to
increased TNF-α release in Yersinia-infected THP-1














































































Figure 2 Secondary RNAi assays for validation of host factors required for Yersinia-mediated suppression of NF-κB signaling. RE-luc2P-
HEK293 cells (20,000/well) were transfected with a 10 nM siRNA pool of four sequences per target gene in a 96-well plate and cultured for 72 h
prior to (A) Y. enterocolitica WA or (B) Y. pestis Ind195 infection at MOI 2 and 10, respectively. Infection was stopped 1 h post-bacteria exposure
by addition of 170 μg/ml chloramphenicol in the culture media. Cells were stimulated 5 h post-infection with 10 ng/ml TNF-α and were further
cultured for 18 h. Cells were lysed and luciferase activity was measured to determine the percentage recovery of NF-κB regulated gene expression
relative to that of uninfected cells. NF-κB-regulated luciferase activity was normalized to the RE-luc2P-HEK293 cell titer for each sample to obtain
relative luciferase units. Numbers above the column data represent the ratio of luciferase activity in bacteria-infected versus uninfected cells.
A “*” denotes significant (p≤0.05) recovery of reporter activity for targeting siRNAs compared to the control non-targeting siRNA (CTL)-treated
cells infected with bacteria. Data was obtained from four independent experiments performed in duplicate.
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consistent with the tissue-specific expression profile
of SGK1 in epithelial cells such as HEK293, but not
in monocyte-like THP-1 cells [29].
Finally, we also tested the effect of H-89, a small
molecule inhibitor of AKT, a downstream mediator of the
PI3K pathway that plays an essential role in cell survival,
migration and adhesion. Although AKT itself was not
classified as a hit in the shRNA screen, we did identify
PIK3R2, a regulatory subunit of PI3K, which acts directly
upstream of AKT. Furthermore, AKT was previously
identified as essential for intracellular growth of another
T3SS pathogen, S. typhimurium [13]. Pre-treatment of
RE-luc2P-HEK293 cells with H-89 had no effect on
NF-κB-regulated luciferase activity in response to either
Y. enterocolitica or Y. pestis infection (Figure 3A, orange
vs black bars). However, H-89 induced a significant
increase of TNF-α production in THP1 cells and NHDC
infected with either Y. enterocolitica or Y. pestis, compared
to untreated cells. (Figure 3B-C, orange vs black bars)
These cell-type specific effects of SGK1 and PI3K/
AKT likely reflect the different host cell tropism,
from epithelial to macrophage cells, exhibited by
Yersinia.Pathogenic Yersinia exploit host pathways regulated by the
receptor tyrosine kinase c-KIT to suppress inflammatory
cytokine release
We next assessed the effect of c-KIT signaling on the
expression profile of 84 human inflammatory genes in
Y. pestis-infected THP-1 cells. We observed >3-fold upre-
gulation of several chemokines, including IL-8, CCL20,
CCL2, and cell adhesion gene VCAM1 in Y. pestis-
infected THP-1 cells compared to uninfected cells
(Figure 4A). In contrast, expression of the early growth
response 1 transcription factor (EGR1) was downregu-
lated >70% in cells infected with Y. pestis. EGR1 has
been previously found to regulate transcription of
several chemokines (e.g. IL-8, CCL2) and cytokines
(e.g TNF-α, IL-6), and to confer responsiveness to
IL-1 and TNF signaling [30,31]. Abrogation of c-KIT
signaling by OSI-930 recovered EGR-1 levels and re-
sulted in a further increase in IL-8, CCL20, IL-1α, and
TNF expression, in THP-1 cells infected with Y. pestis
compared to untreated cells (Figure 4B).
To further explore whether c-KIT function can regu-
late EGR1 and downstream inflammatory gene expres-
sion, we examined the effect of OSI-930 treatment on
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Figure 3 Analysis of host kinase function in Yersinia-mediated immune suppression using small molecule inhibitors. (A) RE-luc2P-
HEK293 cells were pretreated with 1μM OSI-930 (green), 20μM TBB (blue), 10μM CKI-7 (purple), or 10μM H-89 (orange) for 16 h and infected with
Y. enterocolitica WA or Y. pestis Ind195 at MOI 1 and 20, respectively, for 1 h. Following stimulation with 10 ng/ml TNF-α at 5 h post-infection,
luciferase activity was measured 24 h post-infection. Results were determined from two independent experiments performed in triplicate. A ‘*”
denotes that the % NF-κΒ inhibition using the inhibitors was significantly different (p<0.05) compared to the no drug control (black). The relative
NF-κB inhibition by Yersinia infection was determined as a percentage of luciferase activity in bacteria-infected cells relative to luciferase activity in
bacteria-free control cells. (B) THP-1 cells were pretreated with the small molecules and infected with Y. enterocolitica WA or Y. pestis Ind195 at
MOI 5 and 20, respectively, for 1 h. TNF-α levels were determined by ELISA on conditioned media collected 24 h post-infection. Results were
determined from two representative independent experiments performed in quadruplicate. A ‘*” denotes that TNF-α release using inhibitors was
significantly different (p<0.05) compared to the no drug control. Cytokine release in response to purified LPS from E. coli 055:B5 (5μg/ml, light
blue) was used as a control for pro-inflammatory mediator signaling. (C) Normal HDC were pre-treated with the small molecules for 18 h prior
to infection with Y. enterocolitica WA or Y. pestis KIM5-. Bacterial infection was stopped 1 h post-infection with 170 μg/ml chloramphenicol.
TNF-α levels were determined by ELISA on conditioned media collected 24 h post-infection. Statistical analysis was performed on data from 3
experiments performed in quadruplicate. TNF-α release in response to all inhibitor treatments were statistically significant (p<0.05) compared to
no drug controls.
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Inhibition of c-KIT kinase activity by OSI-930 (Figure 4C,
dark gray bar) restored EGR1 transcription >2-fold in
Y. pestis-infected THP-1 cells compared to infected cells
with functional c-KIT (Figure 4C, light gray bar). Similarly,
OSI-930 treatment induced VCAM1, CCL20, and IL-8
transcription upon bacterial infection (Figure 4C, dark vs.
light gray bars), suggesting that c-KIT function is required
for the inhibition of key cytokines and adhesion molecules
by pathogenic Yersinia. Notably, treatment of THP-1 cells
with OSI-930 alone did not significantly change EGR1
transcript levels (Figure 4C, white bar), indicating that
pharmacological inhibition of c-KIT did not initiate a
non-specific immune response mediated by EGR1 in the
absence of bacterial infection. Collectively, these findings
suggest that there is a link between c-KIT function andsuppression of the host immune response by pathogenic
Yersinia and that transcriptional inhibition of EGR1 by
Yersinia is dependent on c-KIT function.
We next studied the role of Yersinia T3SS in suppres-
sion of the host immune response via c-KIT signaling.
The expression profiles of EGR1, IL-8, and CCL20 were
compared in THP-1 cells infected with pathogenic
Y. enterocolitica WA and its non-pathogenic counter-
part, Y. enterocolitica WA-01 (pYV-), cured of the pYV
virulence plasmid (Figure 5A). Inhibition of c-KIT with
OSI930 fully restored EGR1 levels in cells infected with
virulent Y. enterocolitica and significantly recovered
transcription of IL-8 and CCL20 at 5 h and 20 h post-
infection (Figure 5A, dark grey bars). In contrast, we did
not observe any significant effect by the c-KIT inhibitor
OSI930 on EGR1, IL-8, and CCL20 transcription in
Figure 4 Pathogenic Yersinia requires c-KIT activity for suppression of transcription factor and pro-inflammatory cytokine expression.
(A-B) Analysis of signal transduction pathways in Y. pestis-infected THP1 cells in absence of c-KIT. THP1 cells untreated or pre-treated with 1μM
OSI-930 for 18 h were infected with Y. pestis Ind195 at MOI 20 for 1h. RNA was isolated, converted to cDNA, and applied to a RT Profiler PCR Array
for human signal transduction pathway expression analysis. Dot plots compare gene expression profiles between uninfected THP-1 cells and
(A) Y. pestis Ind195-infected THP-1 cells or (B) OSI-930-pretreated, Y. pestis Ind195 infected THP-1 cells. Genes that do not exhibit significant
expression changes between the control and experimental samples are concentrated between the two black lines. The black lines define the
assay cut-off of 3-fold induction or 70% reduction of transcript levels. Genes of interest are highlighted in black. (C) Inhibition of c-KIT recovers
EGR1, chemokine, and cell adhesion transcript levels in pathogenic Yersinia-infected THP1 cells. THP1 cells were pre-treated with 1μM OSI-930 for
18 h or were left untreated prior to infection with Y. pestis Ind195 at MOI 10 for 1 h. EGR1, VCAM1, CCL20, and IL-8 mRNA levels were determined
by Taqman qPCR using total RNA isolated 24 h post-infection. Depicted RNA levels are relative to untreated THP1 control samples and were
calculated using the 2-ΔΔCt formula. A ‘*” denotes that relative RNA levels were significantly different (p<0.05) compared to infected cells
untreated with OSI930. Data is shown from three independent infection experiments performed in duplicate.
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of JNK1, acting downstream of c-KIT signaling, with the
small molecule BI-78D3 [30,32] did not exhibit any pro-
tective effect on gene transcription (Figure 5A, medium
grey bars) at either time point of bacterial infection,
compared to drug-free cells (Figure 6A, light grey bars).
Since accumulation of YopJ/P in host cells upon Yersinia
infection has been previously linked to cell death via ac-
tivation of apoptotic pathways, we assessed cell viability
at various MOIs. We registered no decrease in cell via-
bility in drug-free cells or cells treated with the JNK1 in-
hibitor, even after 20 h post-infection of THP-1 cells with
virulent Y.entorocolitica at MOI 2 of the assay. (data not
shown) Taken together, these findings indicate that c-KIT
function is exploited by YersiniaT3SS to suppress produc-
tion of key transcription factors and cytokines involved in
the regulation of the host immune response.We also show that ~95% depletion of c-KIT transcript
levels by siRNA treatment (Figure 5B) rescued EGR1,
VCAM1, CCL20, and IL-8 gene expression in response
to Y. enterocolitica WA infection in THP-1 cells, com-
pared to infected control cells treated with non-targeting
siRNA (si-CTL) (Figure 5C). Similarly, expression levels
of the NF-κB transcription factors, NF-κB1/p50 and
RelA/p65, were recovered in c-KIT-silenced cells in re-
sponse to Y. enterocolitica WA infection. In the absence
of infection, silencing of c-KIT expression by siRNA did
not induce any significant change in the expression
levels of EGR1 or the tested cytokines and transcription
factors (Figure 5B).
To further investigate the interplay between c-KIT sig-
naling and pathogenic Yersinia, we measured RelA levels
in purified nuclei isolated from untreated or Y. entero-
colitica-infected THP-1 cells (Figure 5D, left panel). In
Figure 5 (See legend on next page.)
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Figure 5 c-KIT signaling is targeted by Yersinia T3SS to suppress pro-inflammatory immune response. (A) THP1 cells were pre-treated
with 1 μM OSI-930 or 1 μM BI-78D3 for 18 h or untreated prior to infection with Y. enterocolitica (pYV+) and Y. enterocolitica (pYV-) at MOI 2. The
RNA levels are presented as fold change versus untreated THP1. Data is shown from three independent infection experiments performed in
duplicate. A ‘*” denotes that relative RNA levels were significantly different (p<0.05) in OSI930-treated cells compared to untreated or BI-78D3-
treated cells. (B) THP-1 cells were transfected with 50 nM siRNA targeting c-KIT or control (si-CTL) and incubated for 48 h. RNA levels are presented
relative to transcript levels in siRNA-treated versus untreated THP-1. Data is shown from two representative experiments. A ‘*” denotes that relative
RNA levels were significantly different (p<0.05) in si-cKIT-treated cells compared to si-CTL-treated cells. (C) THP-1 cells were transfected with 50 nM
siRNA against c-KIT (si-cKIT) or control (si-CTL) siRNA and incubated for 72 h prior to infection with Y. enterocolitica WA at MOI 2 for 1 h. Gene transcript
levels are depicted as a relative ratio to uninfected siRNA-treated THP-1 cells. Data is shown from three independent experiments performed in
duplicate. A ‘*” denotes that relative RNA levels of immune genes were significantly different (p<0.05) in si-cKIT-treated cells compared to si-CTL-
treated cells. (D) THP-1 cells, untreated or pretreated with 1μM OSI-930 for 5 h, were infected with Y. enterocolitica WA at MOI 40 for 45 min. Cell nuclei
were purified, labeled with mouse anti-NF-κB RelA, and analyzed by flow cytometry. (left panel) The mean channel fluorescence was used to determine
the fold change of RelA in the nuclei of Yersinia-infected compared to untreated THP-1 cells (middle panel). The statistical data was derived from two
independent experiments (right panel).
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leased from its cytoplasmic inhibitor, IκBα, and trans-
ported to the nucleus to modulate gene expression [33].
Based on flow cytometric analysis, RelA protein levels
were shown to increase by ~2-fold in the nuclei of
THP-1 cells infected with Y. enterocolitica WA, com-
pared to uninfected cells. (Figure 5D, middle and right
panels) Interestingly, pre-treatment of THP-1 cells with
OSI-930 led to a higher 4-fold increase of nuclear RelA
levels, suggesting that Yersinia targets the c-KIT signal-
ing pathway to suppress post-transcriptional activation
of RelA. Collectively, our data demonstrate that virulent
Yersinia inhibits both transcription and post-transcrip-
tional regulation of key inflammatory proteins via the
c-KIT signaling pathway.Figure 6 Yersinia infection activates c-KIT tyrosine phosphorylation. T
(B) Y. enterocolitica pYV+ or (C) Y. enterocolitica pYV- at MOI 40 for the indic
antibody followed by Protein A Sepharose and were resolved by 8% SDS-P
antibodies. Results from three independent experiments were quantified anc-KIT phosphorylation is induced upon Yersinia infection
independently of T3SS
We next investigated c-KIT phosphorylation to assess
kinase activation in response to Yersinia infection. The
binding of natural ligand SCF to c-KIT has been shown
to induce receptor dimerization, rapid auto-phosphory-
lation of tyrosine residues in the intracellular domain,
and subsequent recruitment of signaling proteins to
activate multiple downstream pathways [34,35]. We
examined c-KIT phosphorylation in THP1 cells using
Western blots, in response to infection with both
Y. enterocolitica virulent (pYV+) and attenuated (pYV-)
strains (Figure 6) c-KIT exhibited maximal phosphory-
lation at ~45 min post-infection in both Y. enterocolitica
strains (Figure 6B and C), compared to SCF-inducedHP-1 cells were stimulated with (A) SCF (50 ng/ml) or infected with
ated time points. Cell lysates were immunoprecipitated with anti-c-KIT
AGE. Western blots were probed with anti-c-KIT and p-Tyr (PY20)
d are presented as percentage of phosphorylated versus total c-KIT.
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http://www.biomedcentral.com/1471-2180/13/249phosphorylation, which peaked at 5 min (Figure 6A),
demonstrating that Yersinia LPS or other surface mol-
ecule can trigger c-KIT signaling, albeit at a delayed rate.
This delayed phosphorylation response to pathogen ex-
posure may stem from the time needed for bacterial
chemotaxis and adhesion to host cells prior to activation
of host signaling pathways.
Differential c-KIT expression at the cell surface in human
dendritic cells
To determine whether there is a link between c-KIT ex-
pression levels and host immune response, we investi-
gated the effect of pathogenic Yersinia infection on pro-
inflammatory cytokine production in human dendritic
cells expressing naturally varying levels of c-KIT. We ob-
tained populations of mature NHDC from seven inde-
pendent human donors and compared the expression
levels of c-KIT using flow cytometry with fluorescently-
labeled c-KIT antibody. Two out of seven donors (D2
and D4) expressed ~2-fold higher c-KIT levels (Figure 7A
and B) compared to the remaining 5 donors (D1, D3,
D5-7). The NHDCs from D2 and D4 also exhibited
greater relative inhibition of TNF-α release upon in-
fection with Y. pestis, compared to the other donor
NHDCs (Figure 7C), demonstrating that increased c-KITFigure 7 Differential response to Y. pestis infection in human dendritic
expression of c-KIT in human dendritic cells. NHDCs (20,000) from seven differ
suspension cells were collected, fixed, labeled with (PE)-conjugated c-KIT (Ab8
acquired to generate histograms and a bar graph (B) that depict fluorescence
control sample (C) was generated from a pool of unlabeled NHDC from the s
inhibition of TNF-α release upon Y. pestis infection. NHDCs from seven donors
donor were plated in 6 replicates (in a 24-well cluster dish): 2 wells were treat
at MOI 20. The inhibition of TNF-α production by Y. pestis-infected cells was d
was generated from an average of four replicates of Y. pestis-infected cells ver
experimental sample was performed in triplicate.expression is associated with increased suppression of
pro-inflammatory cytokine release during Yersinia infec-
tion. These findings are consistent with the increased
production of TNF-α during OSI-930 treatment of
Yersinia-infected THP-1 and NHDC cells (Figure 3), and
suggest that c-KIT may be a potential host biomarker for
susceptibility to Yersinia–mediated suppression of innate
immune response.
Discussion
We have performed a RNAi screen to identify host genes
targeted by a primarily extracellular pathogen, Yersinia.
Most of the identified genes, including c-KIT, SGK, and
CKII, have not been previously linked to pathogen infec-
tion, and thus reveal novel mechanisms of virulence and
host immunity in response to Yersinia infection. Al-
though the RNAi screen was based on Y. enterocolitica
infection, the majority of validated hits were also re-
quired for NF-κB inhibition by Y. pestis. Given the ge-
nomic conservation between Y. enterocolitica and Y.
pestis, the overlapping gene hits are likely to function in
host signaling pathways impacted by common Yersinia
pathogenesis mechanisms, such as the T3SS.
We had originally attempted to optimize a RNAi
screen based on Y. pestis infection, but were unable tocells correlates with naturally-expressed c-KIT levels. (A) Differential
ent donors (D1-7) were cultured in LGM-3 for 4 days. Both adherent and
1) antibody, and subjected to flow cytometry analysis. 10,000 cells were
intensity distribution and mean channel fluorescence intensity. The
even donors. (C) NHDCs that express high levels of c-KIT exhibit increased
were cultured in LGM-3 for 4 days prior to treatment. Cells from a single
ed with LPS (E. coli 055:B5, 5 μg/ml) and 4 wells received Y. pestis Ind195
etermined relative to LPS-treated cells for each donor. The data presented
sus the average of two replicates treated with LPS. The ELISA for each
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analysis of host response. Interestingly, the T3SS of Y.
pestis has been found to be less efficient in cell culture
compared to that of Y. enterocolitica [36,37]. A key me-
diator of Yersinia pathogenesis is the YopP/J effector,
(YopP in Y. enterocolitica and YopJ in Y. pestis), which
induces apoptosis in the host. Although YopP and YopJ
share ~97% sequence identity, YopP exhibits a greater
capacity for accumulation in the host cells, which corre-
lates with enhanced cytotoxicity [23]. We speculate that
the relatively weaker pathogenic effect of YopJ may have
been the basis of difficulty in developing a robust RNAi
screen using Y. pestis.
In this study, we describe a c-KIT-EGR1 signaling
pathway that is targeted by Yersinia during infection. Al-
though c-KIT and EGR1 have not been previously posi-
tioned experimentally in the same pathway to the best of
our knowledge, c-KIT and EGR1 functions can be linked
based on convergence of multiple overlapping pathways
(Figure 8). Activation of c-KIT has been shown to stimu-
late the JNK, MEK/ERK, and PI3K/AKT signaling path-
ways, which can feed into EGR1 [30,31,38] and other
transcription factors to regulate cell growth, differen-




















Figure 8 Schematic of multiple signaling pathways induced by extrac
pro-inflammatory cell response. Cell surface receptors translate ligand b
genes depicted in grey were identified in the RNAi screen in which gene s
in response to TNF-α. Cell stimuli, such as stem cell factor (SCF, black triang
the activation of two key transcription factors NF-κB and EGR1. Bolded trian
signaling proteins. The cartoon includes primary signaling molecules and is
mechanisms in these signaling pathways.EGR1 regulates expression of chemokines (e.g. IL-8,
CCL2) and cytokines (IL-6, TNF-α) and was found to
act synergistically with NF-κB to stimulate IL-8 trans-
cription [41].
Our results support a model in which c-KIT signaling
is targeted by Yersinia T3SS to suppress pro-inflam-
matory responses. Some kinases activated downstream
of c-KIT, such as MEK and PI3K, have been shown to
be inhibited by the Yersinia effectors YopJ and YopH, re-
spectively [9,10,42]. YopJ has also been shown to inhibit
phosphorylation of MKK4/SEK1 and attenuates JNK sig-
naling and subsequent EGR1 activation [43] (Figure 8).
Our findings suggest that downregulation of a receptor
kinase function that leads to NF-κB activation can ameli-
orate the inhibitory effect of Yersinia T3SS. Since we ob-
served that the inhibition of another signaling protein
AKT1 also resulted in higher production of TNF-α by
Yersinia-infected macrophage cells (Figure 3), we hy-
pothesized that upon bacterial infection, multiple signal
transduction pathways are triggered by various host
extracellular and intracellular receptors of pathogen as-
sociated molecular patterns (PAMPs). However, not all
signaling pathways are inactivated by Yersinia during in-









ellular stimuli to activate transcription factors that regulate the
inding into activation of host intracellular signaling pathways. The
ilencing counteracted Yersinia-mediated inhibition of NF-κB activation
le), the natural ligand of c-KIT, initiate cell signaling that converge on
gles depict interactions between Yersinia Yop effectors and host
not a comprehensive description of all known players or feedback
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activated CD14 and TLR4 signaling to p38 and JNK, to
recover NF-KB-driven gene expression [44,45]. This hy-
pothesis is supported by our observations that phar-
macological inactivation of JNK1 using the inhibitor
BI-78D3 did not recover pro-inflammatory gene ex-
pression in THP-1 cells infected with pathogenic Yer-
sinia (Figure 5A), while AKT1 and c-KIT inhibition
resulted in increased TNF-α production in infected
THP-1 and NHDC (Figure 3). Thus, redistribution of
signaling pathways can still lead to mitigation of NF-
κB-regulated immune response during the course of
Yersinia infection.
The exact mechanism of Yersinia activation of c-KIT
remains unclear. The natural ligand of c-KIT, SCF, has
been shown to activate c-KIT phosphorylation within 5
min of treatment [34,35]. In response to Y. enteroco-
litica, c-KIT exhibited maximal phosphorylation at
~45 min post-infection in THP-1 cells by Western blot
(Figure 6), demonstrating that Yersinia infection is cap-
able of stimulating c-KIT activation, albeit via a delayed
response compared to SCF. Since, we observed this de-
layed phosphorylation in both virulent and attenuated Y.
enterocolitica, it may be the case that LPS or other bac-
terial cell surface molecule can mediate host receptor
phosphorylation and/or signaling, rather than solely the
T3SS. We have also shown that inhibition of c-KIT sig-
naling by the small molecule OSI-930 induced an altered
inflammatory gene expression pattern in response to
pathogenic Yersinia that resembled infection by a non-
virulent strain (Figure 5A), further supporting functional
links between c-KIT activity and Yersinia virulence. It
may be the case that Yop effectors either directly or in-
directly modulate c-KIT function following injection into
the host. In preliminary studies, we have found a strong
binding interaction between c-KIT and the T3SS cha-
perone SycE (data not shown). Another possibility is that
Yersinia interacts with lipid rafts containing c-KIT in
the plasma membranes of host cells during the infection
process [46,47]. Activation of receptor tyrosine kinases
by bacterial LPS has been reported previously. For ex-
ample, EGFR transactivation by LPS was induced by p38
and matrix metalloproteases upon TLR4-LPS interaction
and was essential for COX-2 gene expression [48]. In-
creased phosphorylation of EGFR was observed 5–60 min
of treatment with purified LPS.
In the search for host factors whose functions are re-
quired by pathogenic Yersinia to suppress the host in-
nate immune response, we identified additional genes
that belong to common functional networks. For ex-
ample, the SGK and WNK families directly regulate each
other to control osmotic stress and cellular ion balance.
During Yersinia infection, the needle-like T3SS injects
effector proteins into the host, increasing membranepermeability and introducing osmotic stress to the host
[49]. Osmotic stress caused by ion imbalance can acti-
vate SGK1/WNK1 function and modulate downstream
MAPK-ERK signaling pathways [50,51], thus potentially
providing Yersinia with another signaling pathway to
manipulate gene expression. WNK1 is a substrate of
SGK1 during insulin activation of PI3K [52] and can ac-
tivate SGK1 during ENaC regulation [53]. WNK1 also
participates in an epidermal growth factor receptor
(EGFR)-ERK pathway that includes two signaling mole-
cules, MAP3K3 and MEK1/2, which were also identified
as hits from our RNAi screen (Figure 8). A direct pro-
tein-protein interaction between WNK1 and MAP3K3
has been previously demonstrated [54]. MAP3K3 regu-
lates ERK signaling through MEK1/2 and is required for
NF-κB activation [55-57]. The Yersinia effector YopJ has
been reported to catalyze the acetylation of target ki-
nases to inhibit MEK and NF-κB signaling [9,10]. Similar
to c-KIT inactivation, downregulation of WNK1 and
MAP3K3 may shunt the activation of transcription fac-
tors that regulate inflammatory cytokine release to an
alternative signaling pathway.
Several of the RNAi screen hits that impact signal
transduction can be directly linked to regulation of
NF-κB signaling. For example, the catalytic α subunit
of CKII was found to phosphorylate IKKα with high
specificity and to stabilize targeting of IκB for proteo-
somal degradation in response to such cell stressors
as UV radiation and TNF-α [58-60]. NIK/MAP3K14
regulates the alternative NF-κB signaling pathway
[61]. PIK3R2, a regulatory subunit of PI3K, functions
in AKT activation, which leads to phosphorylation of
p50 or activation of IKKα through multiple signaling
pathways [61].
Conclusions
Collectively, our studies have identified multiple host
kinases, that when downregulated, mitigated Yersinia-
mediated suppression of the host primary immune re-
sponse. In particular, c-KIT is of great interest as a
potential biomarker for susceptibility to Yersinia in-
fection, given our preliminary data showing that pri-
mary dendritic cells that express higher c-KIT levels
produced less TNF-α in response to Y. pestis infec-
tion. Furthermore, some of the identified genes and
signaling pathways have been found to be essential
for infection by other bacterial species. For example,
the PI3K pathway is required for successful infection
in Yersinia (this study), Listeria and Salmonella [13,62].
Thus, the RNAi screen hits may represent candidate tar-
gets for development of host-derived therapeutics that in-
hibit not only Yersinia infection, but also potentially a
wide range of bacterial pathogens that employ common
virulence mechanisms.
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Tissue culture cell growth conditions and chemicals
The GloResponse™ NF-κB RE-luc2P-HEK293 cell line
(Promega, Madison, Wisconsin), was cultured in DMEM
(Invitrogen, Carlsbad, CA) supplemented with 10% FBS
(HyClone, Logan, UT), 2 mM glutamine, 1 mM so-
dium pyruvate, and 50 μg ml-1 Hygromycin B (HygB)
(DMEM/10-HygB). For the transfection assays, host cells
were maintained in antibiotic-free DMEM/10% FBS.
THP-1 human monocytes (ATCC TIB-202) were main-
tained in RPMI-1640/10% FBS. Normal human dendritic
cells (NHDC) (LONZA, Allendale, NJ) were cultured in
LGM-3 Growth Medium (LONZA). All media types do
not contain any SCF, the natural ligand of c-KIT. All cell
types were cultured at 37°C and 5% CO2. Phenol-purified
lipopolysaccharide (LPS) from E. coli 055:B5 (Sigma-
Aldrich, St. Louis, MO) was used as a positive control
to induce cytokine release by host cells. The inhibi-
tors TBB, H-89, CKI-7, and BI-78D3 were purchased
from Sigma-Aldrich. OSI-930 was obtained from Selleck
Chemicals (Houston, TX).
Bacterial strains and growth conditions
The following Yersinia strains were used in this study: Y.
pestis medievalis KIM5- (pCD1+, pgm-) [63], Y. pestis
orientalis India195 (pCD1+, pgm+, LANL archive), Y.
enterocolitica WA (pYV+, ATCC 27729), and Y. entero-
colitica WA-01 (pYV-, this study). Strains were routinely
propagated on brain heart infusion agar (Difco, Detroit,
Mich) at 26°C overnight and up to 1 week storage at
4°C. For cell infection experiments, bacteria were grown
at 26°C in brain heart infusion broth for 18 h in an or-
bital shaker at 180 rpm, followed by dilution of the bac-
terial culture to obtain 0.1 OD660 and additional growth
for 2 h at 37°C (100 rpm). The pYV- Y. enterocolitica
strain was obtained by serial passages of Y. enterocolitica
WA on LB agar plates at 37°C. Bacterial clones were iso-
lated and loss of pYV plasmid was monitored by PCR
using primer sets for amplification of yopH and yopJ.
RNAi screen and bacterial infection
The human GIPZ lentiviral shRNAmir kinome library,
consisting of 2503 shRNA constructs targeting 782
genes, and 62 shRNA constructs isolated from the hu-
man druggable library selected to target 26 genes with
heat shock or chaperone activity, were obtained from
Open Biosystems (Thermo Scientific, Huntsville, AL).
The shRNAmir libraries containing plasmid DNA were
arrayed in 96-well plates such that each well contained
one unique and identifiable shRNAmir. The library matrix
was introduced into RE-luc2P-HEK293 cells using a high-
throughput transfection method: 100–200 ng shRNA
plasmid DNA was incubated at RT for 20 min in 20 μl
serum-free MEM containing 600 nl TransIT-Expressreagent (MirusBio, Pittsburgh, PA) and transfected into
2×104 HEK293 cells in 100 μl DMEM/10% FBS. Approxi-
mately 30 h after transfection, culture media was replaced
with DMEM/10% FBS containing 1 μg ml-1 puromycin.
After 72 h of selection, during which >80% of the mock-
transfected cells died, the selection media was removed,
cells were washed with PBS, and then re-suspended
in 200 μl serum-free DMEM containing 1 μg ml-1 trypsin.
The cell suspension (50 μl) was aliquoted to four
white, clear bottom replica plates containing 50 μl
DMEM/20% FBS. Cells were incubated 24h at 37°C prior
to bacterial infection. For a more precise estimation of
multiplicity of infection (MOI), one of the replica plates
was used to calculate the number of host cells with the
Cell Titer-Glo assay (Promega, Fitchburg, WI). A stand-
ard curve that correlates the ALUs to cell number (5000,
10000, 15000, 20000, 25000, and 30000 cells per well)
was determined for every batch of substrate. Two of the
three remaining replica plates were infected with Y.
enterocolitica WA at MOI 5 by addition of bacteria
in 5 μl DMEM/10% FBS, followed by centrifugation
at 200 g for 5 min at RT. The remaining replica plate
was used as a reference control (MOI 0). After 1h at
37°C, 20 μl DMEM/10% FBS containing 800 μg ml-1
of the bacteriostatic antibiotic chloramphenicol was
added to each well in the plates to limit further Y.
enterocolitica growth and to avoid activation of apop-
totic pathways. Applying Cell Titer-Glo (Promega), we
determined that the HEK293 cells infected with Y.
enterocolitica at MOI 5 exhibited maximal inhibition
of NF-κB-driven gene expression in response to TNF-α
stimulation with no or minimal cellular toxicity.
At 5 h post-infection, 25 μl DMEM/10% FBS contai-
ning 50 nM TNF-α was added to all culture plates. The
screen was run once in duplicate plates. At 20h post-
infection, the Cell Titer-Glo assay was used to normalize
NF-κB-driven luciferase activity to the cell titer. Ar-
bitrary luciferase units (ALUs) were measured using
the Synergy2 Multi-Mode Microplate Reader (BioTec,
Winooski, VT). The relative percentage of NF-κB inhib-
ition (R%I) by Yersinia infection was determined using the
formula, R%I = [1-(ALU:MOI 5/ALU:MOI 0)]×100, where
ALU:MOI 5 corresponds to the luciferase activity in
bacteria-infected cells relative to ALU:MOI 0, the lucifer-
ase activity in no infection control.
Hit selection criteria and validation assays
Genes with at least two shRNAmir constructs that re-
sulted in ≥40% (≥ 2 SD) decrease in R%I of NF-κB re-
porter gene activity were chosen for further validation.
Selected hits were analyzed using siGENOME SMART
pool siRNAs from Dharmacon (Thermo Scientific). RE-
luc2P-HEK293 cells (2.5 × 105 per well) were transfected
with a 10 nM siRNA pool of four sequences per target
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enterocolitica WA and Y. pestis Ind195 infection at var-
ious MOI with or without TNF-α stimulation. Total
RNA was isolated using the RNeasy kit (QIAGEN,
Valencia, CA) following the manufacturer’s instructions.
mRNA expression levels were determined by real-time
quantitative PCR (qPCR) with TaqMan Gene Expression
Assays and the TaqMan RNA-to-CT™ 1-Step Kit (Applied
Biosystems, Foster City, CA) using a 7300 real-time cycler
(Applied Biosystems). NF-κB-driven luciferase activity was
quantified using the Cell Titer-Glo assay.
ELISA and Luminex 200-based assays for analysis of
cytokine levels
TNF-α cytokine levels were measured in the culture
supernatant of Yersinia-infected THP-1 cells by ELISA
(BD Biosciences, San Diego, CA) following the manufac-
turer’s instructions. Conditioned media was collected
24 h post-infection and passed through a 0.22 μm syringe
filter for analysis. Cytokine levels in the supernatants
of Yersinia-infected NHDC cultures were determined
by Luminex Immunoassays using Human Cytokine 3-plex
custom-made panels from Invitrogen (Life Technologies,
Carlsbad, CA) and Procarta (Affymetrix, Santa Clara, CA)
on the Luminex 200 platform (Luminex, Austin, TX).
Gene expression assays
We utilized the RT Profiler Human Signal Transduction
PathwayFinder PCR Array, PAHS-014A (SABiosciences/
QIAGEN, Frederick, MD) to profile 84 genes that func-
tion in 18 different signal transduction pathways. Total
RNA (1.5 μg) was isolated 24 h post infection using the
RNeasy Miniprep Kit (QIAGEN) and 1 μg RNA tran-
scribed into cDNA using the RT2 First Strand Kit
(SABiosciences/QIAGEN) following the manufacturer’s
recommendations. The cDNA reactions were added to
RT2 SYBR Green ROX™ qPCR Mastermix (SABiosciences/
QIAGEN) and redistributed on 96-well profiler array
plates. Reaction mixtures were amplified and analyzed on a
7300 real-time cycler (Applied Biosystems). Dot plots
represent array data normalized to beta-2-microglobulin
and internal RT and PCR controls. Data analysis was
performed using an Excel-based template provided by
SABiosciences/QIAGEN. mRNA expression levels of,
EGR1, VCAM1, CCL20, IL-8, NF-κB1, and RelA were
determined by qPCR using TaqMan Gene Expression
Assays (Applied Biosystems).
Western blot analysis of c-KIT
THP-1 cells were infected with Y. enterocolitica at MOI
40 or stimulated with 50 ng/ml SCF (Cell Signaling
Technology, Beverly, MA). Cells (3×106) were harvested
at the indicated time points, washed with PBS, and lysed
in 1 ml buffer A (40 mM Hepes, pH 7.4, 1% TritonX-100, 1 mM EDTA, 150 mM NaCl, 50 mM NaF, 1 mM
sodium orthovanadate, 10 mg/ml leupeptin, 10 mg/ml
aprotinin, and 1 mM PMSF). Lysates were pre-cleared
by incubation with 50 μl Protein A Sepharose (Invitro-
gen, Carlsbad, CA) for 1h at 4°C and centrifuged at
12,000 g for 15 min. c-KIT was enriched from whole cell
lysates by overnight incubation at 4°C with 1 μg mAb
against c-KIT (104D2, Santa Cruz Biotechnology, Santa
Cruz, CA), followed by immunoprecipitation with 50 μl
Protein A Sepharose for 1 hr at room temperature, and
three washes in buffer A. Proteins were eluted by boiling
in NuPAGE LDS Sample buffer (Invitrogen), separated
by SDS-PAGE, and analyzed by Western blot using ei-
ther c-KIT (104D2) or phosphorylated Tyr (PY20, Santa
Cruz Biotechnology, CA) primary antibodies at 1:1,000
dilution. Blots were developed using rabbit anti-mouse
antibody coupled to HRP at 1:10,000 dilution and
the ECL detection system (Amersham/GE Healthcare,
Piscataway, NJ). Densitometry of individual bands
was quantified using the ChemiDoc XRS system
(Bio-Rad, Hercules, CA). The 60 kDa fraction of IgG
was used as an internal loading control, and the per-
centage of phosphorylated c-KIT was calculated based on
the normalized data for both total and tyrosine phos-
phorylated c-KIT.
RelA/p65 activation assays
THP-1 cells were incubated in media, with or without
1 μM OSI-930, for 5 h and then infected with Y. entero-
colitica for 45 min at MOI 40. Cells were pelleted and
incubated in hypotonic lysis buffer NB (10 mM Tris,
pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT, 0.5%
NP-40, 10 mg/ml leupeptin, 10 mg/ml aprotinin, and
1 mM PMSF) for 15 min on ice. Cell nuclei were puri-
fied by centrifugation on 30% sucrose in NB buffer at
800 g for 10 min and resuspended in PBS/3.7% formal-
dehyde. Fixed cell nuclei were blocked in PBS/10% goat
serum/1% BSA/0.1% Triton for 1h, incubated with 1:300
dilution of mouse anti-phospho-NFκB p65 (A-8, Santa
Cruz Biotechnology) for 3 h, followed by 1 h incubation
in 1:500 dilution of goat anti-mouse IgG conjugated to
FITC (Abcam, Cambridge, MA), all at room tem-
perature. After five washes in blocking buffer, the nu-
clei population was analyzed on a FACS CaliburII
(Becton Dickinson, Franklin Lakes, NJ) using a blue
laser (488 nm) and 530/30 emission channel with
CellQuest Pro software.
Flow cytometry analysis of c-KIT levels on cell
membranes
Formaldehyde (3.7%)-fixed NHDCs were rinsed with
PBS containing 50 mM NH4Cl for 15 min. Cells were
blocked with pre-immune heterologous serum (1:10 di-
luted in PBS) for 30 min, washed with PBS and incubated
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sc-13508PE, Santa Cruz Biotech, CA) for 4 h. The cell
populations were acquired using a BD FACS CaliburII in-
strument with the blue laser (488 nm) and 585/42 emis-
sion channel and were analyzed using BD CellQuest Pro
software.
Statistical analysis
Paired two-tailed Student’s t-test was used to calculate
p-values, where ≤0.05 was considered statistically signifi-
cant. To evaluate the robustness of the RNAi screen in a
high throughput setting, the Z-factor was calculated as
Z’ = [1- (3(σp + σn)/[ μp- μn])], where the mean (μ) and
standard deviation (σ) of positive (p, infected with Yersi-
nia), and negative (n, bacteria free) samples were applied.
A standard z-score was used to identify hits from the RNAi
screen. The z-score was based on a raw score defined as
z = (x-μ)/σ, where x is a reporter gene activity from a single
well, μ is the mean reporter gene activity calculated for en-
tire plate including non-silencing shRNA samples, and σ is
the standard deviation of the entire plate.
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